Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia

The presence of KMT2A/AFF1 rearrangement in B-lymphoblastic leukemia (B-ALL) is an independent poor prognostic factor and has been associated with higher rate of treatment failure and higher risk of linage switch under therapy. Blinatumomab has shown promising therapeutic results in refractory or re...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Rui R., Nayer, Zacharia, Hogan, Matthew, Cuevo, Raymund S., Woodward, Kimberly, Heyer, David, Curtis, Christine A., Peterson, Jess F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925828/
https://www.ncbi.nlm.nih.gov/pubmed/31885955
http://dx.doi.org/10.1155/2019/7394619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925828/
https://www.ncbi.nlm.nih.gov/pubmed/31885955
http://dx.doi.org/10.1155/2019/7394619

Ejemplares similares